Scarica l'app Stockscreener
43.20
3.92%
1.63
Dopo l'orario di chiusura:
43.20
Precedente Chiudi:
$41.57
Aprire:
$42.15
Volume 24 ore:
839.86K
Relative Volume:
0.82
Capitalizzazione di mercato:
$9.84B
Reddito:
$5.36B
Utile/perdita netta:
$-111.00M
Rapporto P/E:
-100.54
EPS:
-0.4297
Flusso di cassa netto:
$196.00M
1 W Prestazione:
-1.64%
1M Prestazione:
+22.41%
6M Prestazione:
+19.88%
1 anno Prestazione:
-2.09%
Intervallo 1D:
$41.93
$43.44
Intervallo di 1 settimana:
$41.45
$44.99
Portata 52W:
$31.33
$46.99
Lineage Inc Stock (LINE) Company Profile
Nome
Lineage Inc
Settore
Industria
Telefono
(800) 678-7271
Indirizzo
46500 HUMBOLDT DRIVE, NOVI
Compare LINE vs PLD, PSA, EXR, EGP
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LINE
Lineage Inc
|
43.20 | 9.46B | 5.36B | -111.00M | 196.00M | -0.4297 |
PLD
Prologis Inc
|
143.79 | 132.22B | 8.95B | 3.97B | 4.25B | 3.9703 |
PSA
Public Storage
|
306.66 | 53.01B | 4.86B | 1.92B | 2.88B | 9.6884 |
EXR
Extra Space Storage Inc
|
145.87 | 30.22B | 3.41B | 988.29M | 1.70B | 4.396 |
EGP
Eastgroup Properties Inc
|
198.42 | 10.59B | 737.14M | 292.65M | 417.71M | 5.4968 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-27 | Downgrade | Barclays | Equal Weight → Underweight |
| 2026-03-18 | Iniziato | Compass Point | Buy |
| 2026-01-13 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-07-01 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-04-10 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | Iniziato | Citigroup | Neutral |
| 2025-01-14 | Iniziato | Exane BNP Paribas | Neutral |
| 2024-12-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-09-18 | Iniziato | CapitalOne | Overweight |
| 2024-09-16 | Iniziato | CapitalOne | Overweight |
| 2024-08-19 | Iniziato | Deutsche Bank | Hold |
| 2024-08-19 | Iniziato | Evercore ISI | In-line |
| 2024-08-19 | Iniziato | Goldman | Buy |
| 2024-08-19 | Iniziato | JP Morgan | Overweight |
| 2024-08-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | Iniziato | Mizuho | Neutral |
| 2024-08-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-08-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-19 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-19 | Iniziato | Truist | Buy |
| 2024-08-19 | Iniziato | UBS | Neutral |
| 2024-08-19 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Lineage Inc Borsa (LINE) Ultime notizie
Volatility is reshaping cold chain decision‑making - The National Provisioner
Lineage Shows Early Recovery Signs as Demand Stabilizes, Morgan Stanley Says - Moomoo
Morgan Stanley Raises Price Target on Lineage to $47 From $39, Keeps Equalweight Rating - Moomoo
Cold Storage Co. Says Investors Can't Claim Misleading IPO - Law360
Kuehn Law Encourages Investors of Lineage, Inc. to Contact Law Firm - GlobeNewswire Inc.
Cold Chain Market Research Report to 2032Star Players - openPR.com
Greg Lehmkuhl Newsmaker profile - Crain's Detroit Business
Lineage (BSP:L1NE34) Shiller PE Ratio : (As of May. 29, 2026) - GuruFocus
Lineage Cell Therapeutics (LCTX) price target increased by 14.58% to 5.61 - MSN
LINE Stock Price, Quote & Chart | LINEAGE INC (NASDAQ:LINE) - ChartMill
Analysts Offer Insights on Real Estate Companies: Lineage, Inc. (LINE) and PennyMac Mortgage (PMT) - The Globe and Mail
Wells Fargo Maintains Lineage (LINE) Equal-Weight Recommendation - MSN
Analysts Are Bullish on Top Real Estate Stocks: Equity Residential (EQR), Lineage, Inc. (LINE) - The Globe and Mail
Lineage reports positive 36-month findings on GA cell therapy - Eyes On Eyecare
Newsmaker: Greg Lehmkuhl - Crain's Detroit
Why Lineage, Inc. Stock Is Suddenly Climbing - TipRanks
What Lineage (LINE)'s Q1 Move From Profit to Loss Means For Shareholders - simplywall.st
Assessing Lineage (LINE) Valuation After Q1 Loss And Modest Undervaluation Signal - simplywall.st
The Leadership Lineage Behind Arkansas’ Largest Private Construction Company - Arkansas Business
Lineage, Inc. (LINE) Q1 FFO beat estimates - MSN
Earnings call transcript: Lineage Inc reports Q1 2026 earnings decline, stock dips - Investing.com Nigeria
Lineage, Inc. $LINE Stock Holdings Lifted by Charles Schwab Investment Management Inc. - MarketBeat
Oxford invests $474M in Lineage Logistics; Turner joins board - RENX
Lineage Logistics to acquire GTA-based VersaCold - RENX
Lineage Cell Therapeutics Q1 Earnings Call Highlights - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Lineage Is Maintained at Underweight by Barclays - Moomoo
All you need to know about Lineage, Inc. (LINE) rating upgrade to buy - MSN
NCSoft Posts Record PC Game Sales on Aion 2, Lineage Classic Success - thelec.net
NC's First-Quarter Operating Profit Surges 2,070% on Lineage Classic Success - thelec.net
Lineage Cell Therapeutics, Inc. Common Stock (NY: LCTX - FinancialContent
Lineage Cell Therapeutics (LCTX) Returns To Loss In Q1 2026 Challenging Profitability Narratives - Sahm
Q1 2026 Lineage Cell Therapeutics Inc Earnings Call Transcript - GuruFocus
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2026 Earnings Call Transcript - Insider Monkey
Lineage Q1 2026 slides: flat revenue, rising EBITDA amid stabilization By Investing.com - Investing.com South Africa
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - BioSpace
Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highl - GuruFocus
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Lineage Cell Therapeutics (NYSE: LCTX) reports higher Q1 2026 revenue and continued R&D spend - Stock Titan
Lineage Cell Therapeutics (LCTX) posts Q1 2026 results and advances cell therapy pipeline - Stock Titan
Lineage Cell: Q1 Earnings Snapshot - WKYC
Earnings call transcript: Lineage Inc reports mixed Q1 2026 results amid market volatility By Investing.com - Investing.com South Africa
Lineage Q1 2026 slides: flat revenue, rising EBITDA amid stabilization - Investing.com
Earnings call transcript: Lineage Inc reports mixed Q1 2026 results amid market volatility - Investing.com
Citigroup maintains Lineage (LINE) neutral recommendation - MSN
Lineage Cell Therapeutics Q1 2026 earnings preview - MSN
Lineage: Robots Could Add $30 Per Share (NASDAQ:LINE) - Seeking Alpha
A Look At Lineage (LINE) Valuation After Mixed Q1 2026 Results And Dividend Increase - simplywall.st
Lineage Inc Azioni (LINE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):